Caas Capital Management LP Dexcom Inc Put Options Transaction History

Caas Capital Management LP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 Apr 26, 2024	SELL	$114.22 - $140.1 $1.45 Million - $1.78 Million	-12,700 Reduced 98.45%	200 $27,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $973,820 - $1.6 Million	12,900 New	12,900 $1.6 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $11.2 Million - $13.2 Million	-107,300 Reduced 81.29%	24,700 $2.87 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $6.73 Million - $13.2 Million	99,000 Added 300.0%	132,000 $9.84 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $2.8 Million - $3.88 Million	-29,800 Reduced 47.45%	33,000 $16.9 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $3.55 Million - $4.73 Million	43,800 Added 230.53%	62,800 $26.8 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $3.48 Million - $4.29 Million	-41,000 Reduced 68.33%	19,000 $6.83 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $4.33 Million - $5.8 Million	55,500 Added 1233.33%	60,000 $22.2 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $215,055 - $340,335	4,500 New	4,500 $1.21 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.